Production (Stage)
Merck KGaA
MKKGY
$26.13
-$0.37-1.40%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 1.31% | 0.79% | -0.56% | -2.19% | -2.82% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 1.31% | 0.79% | -0.56% | -2.19% | -2.82% |
Cost of Revenue | -1.51% | 0.85% | 2.88% | 5.29% | 6.81% |
Gross Profit | 3.34% | 0.76% | -2.83% | -6.91% | -8.72% |
SG&A Expenses | 2.47% | 1.88% | -1.32% | -1.79% | -1.61% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -13.94% | -45.41% | 189.48% | 38.16% | -19.94% |
Total Operating Expenses | -1.43% | -1.26% | 3.82% | 3.42% | 2.57% |
Operating Income | 14.43% | 10.37% | -17.64% | -23.39% | -22.33% |
Income Before Tax | 5.46% | 1.57% | -7.16% | -14.17% | -15.56% |
Income Tax Expenses | 19.20% | 15.54% | -13.17% | -22.46% | -26.54% |
Earnings from Continuing Operations | 2.25% | -1.63% | -5.55% | -11.91% | -12.50% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 42.41% | 17.79% | 41.20% | 51.52% | 16.61% |
Net Income | 2.45% | -1.57% | -5.38% | -11.72% | -12.48% |
EBIT | 14.43% | 10.37% | -17.64% | -23.39% | -22.33% |
EBITDA | 10.30% | 7.57% | -9.94% | -14.59% | -13.95% |
EPS Basic | 2.41% | -1.47% | -5.28% | -11.57% | -12.32% |
Normalized Basic EPS | 14.39% | 10.45% | -11.66% | -17.71% | -18.98% |
EPS Diluted | 2.49% | -1.39% | -5.36% | -11.65% | -12.39% |
Normalized Diluted EPS | 14.39% | 10.45% | -11.66% | -17.71% | -18.98% |
Average Basic Shares Outstanding | 0.02% | -0.11% | -0.11% | -0.17% | -0.17% |
Average Diluted Shares Outstanding | 0.02% | -0.11% | -0.11% | -0.17% | -0.17% |
Dividend Per Share | -0.99% | -0.99% | 5.37% | 5.37% | 5.37% |
Payout Ratio | -0.11% | -0.10% | -0.06% | 0.00% | 0.36% |